Raju Mohan - Dec 22, 2022 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher W. Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Dec 22, 2022
Transactions value $
-$1,749,640
Form type
4
Date filed
12/23/2022, 05:35 PM
Previous filing
Dec 20, 2022
Next filing
Jan 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTYX Common Stock Sale -$1.75M -55.4K -3.34% $31.61 1.6M Dec 22, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F2 Represents the weighted average share price of an aggregate total of 55,354 shares sold in the price range of $31.60 to $31.887. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.